Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00084747
What this trial is testing

Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Jonsson Comprehensive Cancer Center 30
Early research (Phase 1)Looking for participantsNCT06440135
What this trial is testing

Ziftomenib Maintenance Post Allo-HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionNPM1 Mutation+1 more
Massachusetts General Hospital 22
Not applicableStudy completedNCT01092026
What this trial is testing

Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells

Who this might be right for
Allogeneic Stem Cell Transplantation
Universitair Ziekenhuis Brussel 11
Not applicableStudy completedNCT04976933
What this trial is testing

Post-HSCT Medication Adherence mHealth App

Who this might be right for
Stem Cell Transplantation
Micah Skeens 15
Testing effectiveness (Phase 2)Study completedNCT02206035
What this trial is testing

Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
William R. Drobyski, MD 45
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Post-approval studies (Phase 4)Ended earlyNCT03490396
What this trial is testing

Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

Who this might be right for
Oral Mucositis
Midatech Pharma US Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT03850366
What this trial is testing

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

Who this might be right for
Hematological Malignancy
Henry Ford Health System 15
Large-scale testing (Phase 3)UnknownNCT03846362
What this trial is testing

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

Who this might be right for
Acute Myeloid Leukemia, Childhood
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 500
Early research (Phase 1)Study completedNCT02264873
What this trial is testing

Phase I, Dose Escalation Study of Decitabine

Who this might be right for
Leukemia, Lymphoblastic, AcuteLeukemia, Myeloid AcuteHematopoetic Myelodysplasia
University of Florida 3
Large-scale testing (Phase 3)UnknownNCT04756622
What this trial is testing

N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.

Who this might be right for
MucositisTransplant-Related Disorder
moshe yeshurun 116
Testing effectiveness (Phase 2)Study completedNCT01208896
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma

Who this might be right for
Lymphoma, FollicularStem Cell Transplantation
University Hospital, Bordeaux 32
Not applicableEnded earlyNCT01700816
What this trial is testing

Prevention of Delirium After Bone Marrow Transplantation

Who this might be right for
Delirium
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05982275
What this trial is testing

Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant

Who this might be right for
Multiple MyelomaAllogeneic Stem Cell Transplantation
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 25
Early research (Phase 1)Study completedNCT02669199
What this trial is testing

MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound

Who this might be right for
MSCs
Chinese PLA General Hospital 20
Large-scale testing (Phase 3)Study completedNCT01602211
What this trial is testing

INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant

Who this might be right for
Cancer SurvivorDepressionHematopoietic and Lymphoid Cell Neoplasm+1 more
Fred Hutchinson Cancer Center 1,600
Large-scale testing (Phase 3)UnknownNCT03967665
What this trial is testing

Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution

Who this might be right for
Stem Cell Transplant Complications
Peking University People's Hospital 130
Early research (Phase 1)Study completedNCT00008177
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+14 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03298412
What this trial is testing

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

Who this might be right for
High-risk Diffuse Large B-cell Lymphoma
Amgen 10
Next Page
79